Skip to main content
PLOS One logoLink to PLOS One
. 2023 Feb 22;18(2):e0281992. doi: 10.1371/journal.pone.0281992

Telemonitoring for perioperative care of outpatient bariatric surgery: Preference-based randomized clinical trial

E S van Ede 1,2,*,#, J Scheerhoorn 3,#, M P Buise 1, R A Bouwman 1,2, S W Nienhuijs 3
Editor: Steven E Wolf4
PMCID: PMC9946229  PMID: 36812167

Abstract

Importance

Implementation of bariatric surgery on an outpatient basis is hampered by concerns about timely detection of postoperative complications. Telemonitoring could enhance detection and support transition to an outpatient recovery pathway.

Objective

This study aimed to evaluate non-inferiority and feasibility of an outpatient recovery pathway after bariatric surgery, supported by remote monitoring compared to standard care.

Design

Preference-based non-inferiority randomized trial.

Setting

Center for obesity and metabolic surgery, Catharina hospital Eindhoven, the Netherlands.

Participants

Adult patients scheduled for primary gastric bypass or sleeve gastrectomy.

Interventions

Same-day discharge with one week ongoing Remote Monitoring (RM) of vital parameters or Standard Care (SC) with discharge on postoperative day one.

Main outcomes

Primary outcome was a thirty-day composite Textbook Outcome score encompassing mortality, mild and severe complications, readmission and prolonged length-of-stay. Non-inferiority of same-day discharge and remote monitoring was accepted below the selected margin of 7% upper limit of confidence interval. Secondary outcomes included admission duration, post-discharge opioid use and patients’ satisfaction.

Results

Textbook Outcome was achieved in 94% (n = 102) in RM versus 98% (n = 100) in SC (RR 2.9; 95% CI, 0.60–14.23, p = 0.22). The non-inferiority margin was exceeded which is a statistically inconclusive result. Both Textbook Outcome measures were above Dutch average (5% RM and 9% SC). Same-day discharge reduced hospitalization days by 61% (p<0.001) and by 58% with re-admission days included (p<0.001). Post-discharge opioid use and satisfaction scores were equal (p = 0.82 and p = 0.86).

Conclusion

In conclusion, outpatient bariatric surgery supported with telemonitoring is clinically comparable to standard overnight bariatrics in terms of textbook-outcome. Both approaches reached primary endpoint results above Dutch average. However, statistically the outpatient surgery protocol was neither inferior, nor non-inferior to the standard pathway. Additionally, offering same-day discharge reduces the total hospitalization days while maintaining patient satisfaction and safety.

Introduction

Metabolic surgery accounts for a significant portion of healthdot resources for perioperative care. The high volumes of these procedures results in thousands of admissions per year [1], with the associated workload, patient burden [2] and hospital costs [3]. Enhanced Recovery After Bariatric Surgery protocols reduced the length of hospital stay after bariatric surgery without negative impact on morbidity or mortality [4]. The next step is a further reduction of length of stay to ambulatory [5] care. However, implementation of bariatric surgery on an outpatient [5] basis is hampered by concerns about timely detection of postoperative complications [68]. Severe events such as bleeding or anastomotic leakage requiring short term re-intervention occur in around 0.5–5% [9, 10] and are most often manifested by changes in vital signs, such as tachycardia and increased respiration rate [11, 12]. Therefore, patients frequently are hospitalized overnight for observation.

Non-invasive monitoring devices can be used remotely after bariatric surgery [13, 14] and could support the transition to an outpatient recovery pathway. It was recently suggested that same-day discharge after gastric bypass with additional remote monitoring is feasible [15]. However, this study was conducted on a relatively small and select population using non-continuous remote measurements operated by the patients themselves which could increase the risk of missing data which limits trend analysis. Additionally, recent evidence suggests the advantages of continuous measurement of vital signs over intermittent measurements [1618]. Nevertheless, despite these early promising results, studies on the feasibility and safety of using remote monitoring devices for patients after surgery remain limited.

The aim of this patient preference randomized trial was to establish and evaluate non-inferiority and feasibility of an outpatient recovery pathway after bariatric surgery, supported by remote monitoring compared to standard care.

Methods

Trial design

This preference-based non-inferiority study was designed to compare the outcomes of two different recovery pathways after bariatric surgery in the Catharina Hospital, Eindhoven, The Netherlands. A detailed protocol of the study has been published [19]. The trial was registered at ClinicalTrials.gov (Identifier NCT04754893), and approved by the Medical Ethical Committee of the Maxima Medical Center, the Netherlands (Reference number W20.095). Standard care (SC) was discharge on postoperative day one after one overnight admission. In the intervention group, patients were discharged the same-day which was supported by remote monitoring (RM) using the Healthdot system (Philips Electronic Nederland BV) for seven days after surgery.

Trial population

Patients were eligible to participate if scheduled for a primary Roux-en-Y gastric bypass or sleeve gastrectomy, if they were 18 years and older, had no allergy to white plasters, no pacemaker and someone nearby in their household the first night. After given written informed consent, patients were allocated to one of two trajectories conforming their preference. Patients without preference were randomly assigned to a study group. For this, the researchers used an online randomization software (random.org/lists/) that allocated patients based on the spots still available at that time.

Telemonitoring

The Healthdot is a validated wearable data logger [13]. Attached mid-clavicular on the lowest left rib on the chest, it collects heart rate, respiratory rate, activity and posture continuously by means of accelerometer signals. Every five minutes, the mean of these values was transmitted and visualized in trend graphs in the Guardian Intellivue dashboard (Philips Electronic Nederland BV). A warning score was calculated for events with a heart rate and respiration rate above a pre-defined threshold of 110 beats per minute and 20 breaths per minute respectively [20]. These values were based on literature and clinical experience of the medical team. If the warning score remained elevated for 15 minutes, which means 3 data points, a notification was generated.

Procedures

Patients from both study groups received equal perioperative care according to the Enhanced Recovery After Bariatric Surgery guidelines [21] and postoperative care in accordance with the hospitals’ protocol for bariatric surgery. Patients allocated to the RM group were scheduled in the morning for the earliest time-slots. The Healthdot was applied in the recovery room directly after surgery. Discharge took place in the evening at the discretion of a nurse under supervision of a doctor. The patient had to feel well and be motivated to go home. Furthermore, hemoglobin decrease should not exceed 3.2 g/dL compared to preoperative value and the spot-check measured heart rate should be less than 100 beats per minute. Teleconsultation with a physician was scheduled on postoperative day one to assess physical condition. Vital signs were reviewed by the treatment-team every morning for up to seven days postoperatively and assessed over the past twenty-four hours to determine if additional action was indicated. The treatment-team had access to the vital signs, including any notification, only when logged into the dashboard. There were no active notifications sent to the clinicians. If a notification was seen after logging in, the patient received an additional teleconsultation. In case a patient contacted the hospital, the vital signs dashboard was also reviewed. Patients receiving standard care remained in hospital overnight and discharged under the same conditions as the patients in the RM group. If these criteria were not met, patients stayed on the ward with ongoing spot check and lab monitoring if needed.

Outcomes

Included in analysis were patient characteristics, comorbidities and surgery details according to Dutch Audit for Treatment of Obesity (DATO) definitions [22]. The primary outcome was a combined measurement of mortality, mild and severe complications (Clavien-Dindo 2 and higher), hospital readmission or prolonged length of stay (>2 hospitalization days after surgery), within 30 days after surgery; also known as Textbook Outcome [23]. Meeting this Textbook Outcome means that the patient has shown a perfect convalescence. If Textbook Outcome was not met, the most severe complication was assigned per patient. The total number of hospitalization days including readmission days, were calculated for each study group and specifically for the two types of surgery in the RM group. Per postoperative day, the number of patients who were discharged on that day was determined. The reason for failure of same-day discharge and teleconsultations on postoperative day one was inventoried. In addition, patient satisfaction and use of pain medication after discharge were assessed as secondary outcome. Patient satisfaction was assessed by a questionnaire which was completed by all patients on the seventh’ day after surgery. In one of the questions, an overall score of 0–10 that reflects the general satisfaction of the perioperative pathway from surgery to one week after surgery was asked.

Statistical analysis

Sample size calculation was performed by using uncorrected chi-square statistic and resulted in 97 patients per group to test with 80% power and an expected proportion of 0.96 whether Textbook Outcome of RM would not be inferior to SC [22]. In current practice, 95% of the patients who undergo bariatric surgery at the Catharina Hospital in Eindhoven meet this outcome measure. Related to the Dutch average of 88.7% [23], a non-inferiority margin of 7% was determined. The calculated non-inferiority margin for the relative risk (RR) difference from the assumed number of events was 2.75 (4%+7%)/4% ([expected event rate control group + non-inferiority margin] / expected event rate) [24]. All endpoint analyses were performed according to the intention-to-treat (ITT) principle [25]. In addition, a per protocol (PP) analysis was performed for the primary outcome. Results of the primary outcomes were presented in RR and in absolute risk difference (ARD) with a two-sided 95% confidence interval (CI) (Consort 2010, non-inferioty and equivalence trials, 17b). Non-inferiority was declared if the upper limit of the 95% CI of RR was < 2.75 and the ARD was < 7%. To demonstrate statistical significance of non-inferiority, p-value of <0.05 is needed (one-sided), calculated by using an asymptomatic score test (Wald’s method) [26].

Interim analysis occurred after complete follow-up of 50 patients in each study group. Based on the results, it was decided by the research team whether the study could continue. Differences between group characteristic means, satisfaction scores were assessed with the use of an independent t-test and the total admission days with a non-parametric test (Mann-Whitney U). Differences between proportions of group characteristics were assessed with a chi-square or Fisher’s exact test. Group means, admission duration, opioid use and satisfaction scores were considered statistically different at a two-tailed p-value less than 0.05. All analysis were performed by the research team with support of in-hospital statistician and clinical epidemiologist using IBM SPSS Statistics version 25.0 and the sample size calculation by Power and Sample Size Calculation software (v3.1.2, Vanderbilt University).

Results

Population

From March 2021 until November 2021, a total of 336 participants underwent screening of whom 208 consented participation and were asked for their preference. Of these patients, 103 preferred RM and 102 preferred SC. Additionally, three patients without a specific preference were randomly assigned into to the RM (n = 2) and SC group (n = 1). In total, 202 patients were analyzed (RM n = 102, and SC n = 100). Fig 1 shows an overview of the enrollment, treatment and follow-up. Baseline patient characteristics were comparable in both groups and are summarized in Table 1.

Fig 1. Enrollment, randomization, and follow-up (Consort 2010 Flow Diagram).

Fig 1

RM = remote monitoring group. SC = standard care group.

Table 1. Patient characteristics.

Patient Characteristics
Characteristic RM SC
(n = 102) (n = 100)
Age—years 40 ± 11.3 41 ± 11.7
Female–N (%) 83 (81) 86 (86)
Male–N (%) 19 (19) 14 (14)
Median body mass index § (IQR) 42 (39–46) 41 (39–44)
ASA–N (%)
2 22 (22) 20 (20)
3 80 (78) 79 (79)
4 0 (0) 1 (1)
Hypertension–N (%) 25 (24.5) 30 (30)
Diabetes Mellitus type II–N (%) 7 (7) 13 (13)
Gastroesophagal reflux disease–N (%) 14 (14) 16 (16)
Musculoskeletal pain–N (%) 28 (28) 35 (35)
Obstructive Sleep Apnea Syndrome–N (%) 8 (8) 14 (14)
Surgery type–N (%)
Sleeve gastrectomy 54 (53) 49 (49)
Roux-en Y Gastric Bypass 48 (47) 51 (51)
Surgery duration—minutes 53 ± 17.5 52 ± 15.6

There were no statistical differences between the study groups. No data was missing. Plus-minus values are means ±SD. §Body mass index is the weight in kilograms divided by the square of the height in meters.

In total 102/102 patients were included for ITT and 66/102 for PP analyses as not all patients managed to be discharged the day of the surgery (see also Table 2 and hospitalization days paragraph).

Table 2. Primary endpoint (textbook outcome) according to ITT analysis.

RM SC Risk ratio (95% CI)
n = 102 n = 100 P-value
Textbook Outcome 94% 98% 2.9 (0.60–14.23) p = 0.22
N (%) N (%)
Mortality 0 0
Severe complications 3 (3) 0
Mild complications 2 (2) 1 (1)
Readmission 1 (1) 1 (1)
Prolonged length of stay 0 0

No data was missing.

Primary endpoints

Textbook Outcome was achieved in 96/102 (94%) in the RM group versus 98/100 (98%) in the SC group (Table 2). The PP result was 62/66 (94%) in the RM group versus 98/100 in the SC group. According to ITT analysis, the RR comparing Textbook Outcome measures between RM and SC was 2.9 (95% CI, 0.60–14.23, p = 0.22) and ARD 3.8% (95% CI, -1.45–9.2). For PP, a RR of 3.0 (95% CI, 0.57–16.07, p = 0.26) and ARD of 4.1% (-2.3–10.44) was calculated. The upper limits of the 95% CI crossed the specified non-inferiority margins, indicating that the results were statistically inconclusive [27]. Further, Textbook Outcomes of both groups were above the Dutch average of 88.7% (RM 5.3% and SC 9.3%).

No mortality was encountered. Mild complications registered in the RM group were a prescription of oral antibiotics to treat an infected hematoma and a endoscopic clipping on postoperative day one requiring readmission after initial same-day discharge. In the SC group, a Computed Tomography of the cerebrum was performed on a patient who had fallen on postoperative day one, while still admitted in hospital. The scan showed no abnormalities. Severe complications included three patients from the RM group who required re-surgery due to postoperative bleeding. Two of these patients were readmitted on postoperative day two after initial same-day discharge. The third patient underwent re-surgery on postoperative day two and remained in hospital for four consecutive days. These patients with a complicated postoperative course did not use anticoagulation medication. Beside these complications, none of the patients had a prolonged hospital stay. In the RM and SC groups each, one patient was readmitted on postoperative day one after teleconsultation and on day four, respectively. Both readmissions were for observation of nausea and vomiting (Clavien-Dindo 1). There was no need to administer intravenous fluids.

Hospitalization days

Discharge on postoperative day zero was achieved in 66/102 (65%) of RM patients. In 30/102 (29%), the patients went home on postoperative day one. The total amount of hospitalization days was significantly lower in the RM group (61% p<0.001 concerning initial hospital stay and 58% p<0.001 when including readmissions) (Table 3). No differences were found in the total number of hospital days of patients in the RM group who underwent a RYGB or an SG (21 versus 23 days, respectively).

Table 3. Hospitalization days.

RM SC P-value
Patients Days Patients Days
1 day 30 30 88 88
2 days 5 10 12 24
4 days 1 4 0 0
Readmission days 3 6 1 2
Total days 50 114 P < 0.001

The total number of admission and readmission days and the difference between study groups is presented. ‘Patients’: number of patients discharged on the corresponding postoperative day. ‘Days’: cumulative number of days spend in the hospital by these patients.

Patient satisfaction

The reasons not being discharged on the same-day for the 36 patients of the RM group are shown in Table 4. Patient’s doubts and nausea were most common. The remaining patients (n = 66) received a scheduled teleconsultation postoperatively. Of this group, 12 patients had a total of 14 issues to report during that consultation. During the entire first postoperative day, a total of 22/66 patients (33%) had 26 issues to report that, in addition to the scheduled consultations, could be managed with 15 additional phone calls. Most commonly mentioned issues were pain and nausea. Except for two readmissions and one assessment in the clinic, all patients could be counseled or treated on a remote basis. Patients who received remote care were equally satisfied compared to patients in the SC group (8.0 ± 1.6 versus 8.0 ± 1.4 respectively p = 0.86, 95% CI -0.4–0.5). Satisfaction scores were missing of 12 patients in SC group and 3 patients of the RM group who were discharged the same-day. In addition, patients from both groups were prescribed the same amount of opioids after being discharged (10/102 (11%) versus 9/100 (9%) in SC group p = 0.82).

Table 4. Reasons for not achieving same-day discharge versus issues during teleconsultation.

RM–no. (%)
Reasons for not achieving same-day discharge
    • Tachycardia
    • O2 suppletion
    • Surgical
    • Nausea
    • Pain
    • Not comfortable with discharge
    • No transport available (1)
    • Diabetes protocol not stopped in time (1)
5 (5.0%)
2 (2.0%)
1 (1.0%)
9 (8.8%)
5 (4.9%)
12 (11.8%)
1 (1.0%)
1 (1.0%)
Issues during teleconsultations on postoperative day 1 (66 patients)
Issue Care
Nausea 8 (12%)     • Conservative care 1 (12.5%)
    • Anti-emetics 5 (62.5%)
    • Follow-up* 1 (12.5%)
    • Readmission 1 (12.5%)
Pain 14 (21%)     • Conservative care 6 (43%)
    • Follow-up* 2 (14%)
    • Opiods 5 (36%)
    • Assessment clinic 1 (7%)
Heartburn 1 (1.5%) Conservative care 1 (100%)
Collapse 1 (1.5%) Readmission 1 (100%)
Notification 2 (3%) No action needed 2 (100%)
*Follow-ups 3 (4.5%) Conservative care

Upper: reasons failure same-day discharge of patients in the RM group, in % patients of the total RM group (n = 102) and number of patients (no.). Lower: issues during planned teleconsultations on postoperative day one, in % of total patients receiving teleconsultations (n = 66) and number of patients (no.). Follow-up: additional call to assess the result of advice or treatment given or to reassure the patient.

Adverse events

There were no adverse events during the study. Three of the 102 patients wearing Healthdot developed a minor rash on monitoring day 5 (n = 2) and day 7. After a physician’s assessment of safety, the patch was removed from these patients.

Discussion

In adult patients who undergo primary bariatric surgery, an outpatient pathway supported with telemonitoring is clinically comparable to standard overnight bariatrics in terms of textbook-outcome. Both approaches reached primary endpoint results above Dutch average. Also, the patient-preferred outpatient recovery pathway with remote monitoring resulted in significantly fewer hospitalization days without compromising patient satisfaction and safety.

Statistically the outpatient surgery protocol was neither inferior, nor non-inferior to the standard pathway. An explanation could be that the standard group had a higher outcome score (98%) than the expected 96% on which the sample size is based [24]. With the outcomes observed in the control group, a larger number of patients would have been required for ITT and especially PP analysis to establish non-inferiority. The number of events in both groups is also very low, so that a small increase in the difference of Textbook Outcomes between groups has major consequences for the confidence interval.

This study evaluated same-day discharge for both sleeve gastrectomy and gastric bypass without any comorbidity restriction. Previous studies had a retrospective design, except for a recently conducted randomized controlled study [28], and focus on one specific technique, more patients’ selection criteria and no comparison with an overnight hospital stay [68, 15, 2832]. The outcome parameters used in previous research are comparable to the combined Textbook results in our current study.

No mortality was encountered, although the group size was small in this matter. Nevertheless, in review the mortality rates of outpatient post-bariatric patients did not differ statistically from patients hospitalized overnight, with the exception of Inaba and Morton et al [68]. The latter ones attributed the increase mortality to an increased number of cardiopulmonary complications requiring resuscitation, unplanned intubation and Intensive Care admission requirements. The authors hypothesized that this may be due to a poor assessment of the patient’s risk prior to surgery and failure to rescue the patient in an unsupervised environment [68]. Extended monitoring of patients, during the most risky hours after surgery, could help clinicians detect complications. With higher data density, it may also even be possible to determine more accurately the timing of the discharge. However, the added value of continuous remote monitoring in post-bariatric patients is currently anecdotal as no data or literature is available yet regarding improving survival and morbidity.

No significant differences were found for readmission and reoperation. One patient was readmitted within the same-day discharge period because of collapse and abnormal trend analyses found at teleconsultation on postoperative day one. Two patients undergoing outpatient care required readmission on postoperative day two due to postoperative bleeding. As no abnormalities were revealed from teleconsultation and vitals on postoperative day one, they did not seem to be related to the same-day discharge pathway. Even an hypothesis of more straining at home was considered unlikely as a tachycardia was expected to occur within 8–24 hours of surgery [11] for these late bleedings. In both cases, treatment was not started too late. If standard care had been provided, the clinical course would not have been different since the patients could be discharged home anyway.

The current study showed a halved length of stay in the RM group, not excluding any patient groups and taking patient preference into account. Recently, Nijland et al. were the first to conduct a prospective study combining same-day discharge with remote monitoring. A success rate of 88 percent was achieved, which was higher than in our cohort. The authors noted that specific preparation in the preoperative pathway was a positive factor contributing to this success [15]. Comparable to the study of Aftab et al [5], our results showed quite some impact of patients hesitation regarding early discharge due to nausea. On the other hand patients with the same complaints however willing to go home achieved same satisfaction, suggesting that this is feasible. In our design there was less focus on preparation for same day discharge allowing an unstrained preference of the patients. Success rate is expected to increase if the expectation management of patients takes on a more central role in the implementation of the outpatient recovery trajectory and the remote monitoring device applied only after fulfilling the criteria to be discharged.

Strengths

Clinical trials preferably include random assignment. However, implementation of results of such trials can be hampered by reduced external validity. Adding patient preferences can limit this effect without compromising internal validity [33]. Randomization of patients can actually lead to bias, as there is a chance that the patient would not be motivated if the recovery trajectory was not preferred. In addition, besides including patients’ preference mimics current daily practice, stimulating patient autonomy is important to empower confidence and self-care which may benefit short-term and long-term outcomes.

Limitations

No real-time notifications were used during the telemonitoring period in the outpatient recovery pathway. Hypothetically, incorporating real-time alarms into daily practice may improve patient safety and outcome measures, while also negatively impacting workload and induce alarm burden. Future reports will evaluate the performance of the currently used follow-up and notification protocol on complication detection. The results of this study were applicable to Dutch bariatric surgical patients. It can be imagined that this may not be the case for every bariatric surgical center as the composition of patient characteristics varies.

The added value of continuous remote monitoring on morbidity and mortality after general or bariatric surgery has not been established yet. Large datasets and future studies are needed to elaborate on this aspect, but also to improve monitoring and alarming techniques [3437]. Nevertheless, we envision that the results and experiences gained from the outpatient monitoring pathway in the present study, can serve as a blueprint for rolling out telemonitoring for other perioperative care pathways.

In conclusion, without any restriction on comorbidities, outpatient bariatric surgery supported with telemonitoring is clinically comparable to standard overnight bariatrics in terms of textbook-outcome. Both approaches reached primary endpoint results above Dutch average. However, statistically the outpatient surgery protocol was neither inferior, nor non-inferior to the standard pathway. Additionally, offering same-day discharge reduces the total hospitalization days while maintaining patient satisfaction and safety.

Supporting information

S1 Checklist

(PDF)

S1 File. Study protocol.

(PDF)

S2 File

(PDF)

Acknowledgments

This study was initiated from the Eindhoven MedTech Innovation Center (e/MTIC), the project is a collaboration of the Catharina Hospital in Eindhoven, Technical University of Eindhoven, and Philips Research of the Netherlands. The authors wish to thank the Philips research-team for their constructive and practical contributions and Philips Healthdot-team for technical support during clinical use of Healthdot.

The authors would like to express their gratitude to:

Yentl Lodewijks and Friso Schonck, Catharina Hospital Eindhoven, Eindhoven, The Netherlands: MD, PhD-candidates who helped conducting the study.

Department of the Obesity Clinic and Surgery Planning, Catharina Hospital Eindhoven, Eindhoven, The Netherlands: Supported planning concerning inclusion and surgery.

Department of clinical physics and technical engineering, Catharina Hospital Eindhoven, Eindhoven, The Netherlands: enabling implementation of new medical device and provide technical logistics support.

Department of Pharmacy, Catharina Hospital Eindhoven, Eindhoven, The Netherlands: enabling new pathway of dispensing postoperative medication.

Saskia Houterman and Sylvie Kolfschoten Department of education and research, Catharina Hospital Eindhoven, Eindhoven, The Netherlands: helped performing statistics.

Marcel van ‘t Veer; Research and development, hartcentrum & Wetenschapsbureau Catharina Hospital Eindhoven, Eindhoven, The Netherlands: helped performing statistics.

Data Availability

The file ia available from the Open Science Framework database Accession number: DOI 10.17605/OSF.IO/256MN).

Funding Statement

Philips Electronics Nederland BV, acting through research, Eindhoven, NL supplied the wearables used in this study, of which information is included in the protocol. Philips Eindhoven did not play a role in any of the following: The study design, data collection, analysis, decision to publish or preparation of the manuscript.

References

  • 1.Angrisani L, Santonicola A, Iovino P, Ramos A, Shikora S, Kow L. Bariatric Surgery Survey 2018: Similarities and Disparities Among the 5 IFSO Chapters. Obes Surg. 2021. May;31(5):1937–1948. doi: 10.1007/s11695-020-05207-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Palmer PK, Wehrmeyer K, Florian MP, Raison C, Idler E, Mascaro JS. The prevalence, grouping, and distribution of stressors and their association with anxiety among hospitalized patients. PLoS One. 2021. Dec 6;16(12):e0260921. doi: 10.1371/journal.pone.0260921 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ibrahim AM, Ghaferi AA, Thumma JR, Dimick JB. Hospital Quality and Medicare Expenditures for Bariatric Surgery in the United States. Ann Surg. 2017. Jul;266(1):105–110. doi: 10.1097/SLA.0000000000001980 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zhou J, Du R, Wang L, Wang F et al. The Application of Enhanced Recovery After Surgery (ERAS) for Patients Undergoing Bariatric Surgery: a Systematic Review and Meta-analysis. Obes Surg. 2021. Mar;31(3):1321–1331. doi: 10.1007/s11695-020-05209-5 [DOI] [PubMed] [Google Scholar]
  • 5.Aftab H, Fagerland MW, Gondal G, Ghanima W, Olsen MK, Nordby T. Gastric sleeve resection as day-case surgery: what affects the discharge time? Surg Obes Relat Dis. 2019. Dec;15(12):2018–2024. [DOI] [PubMed] [Google Scholar]
  • 6.Morton JM, Winegar D, Blackstone R, Wolfe B. Is ambulatory laparoscopic Roux-en-Y gastric bypass associated with higher adverse events? Ann Surg. 2014. Feb;259(2):286–92. doi: 10.1097/SLA.0000000000000227 [DOI] [PubMed] [Google Scholar]
  • 7.Inaba CS, Koh CY, Sujatha-Bhaskar S, Zhang L, Nguyen NT. Same-Day Discharge after Laparoscopic Roux-en-Y Gastric Bypass: An Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program Database. J Am Coll Surg. 2018. May;226(5):868–873. doi: 10.1016/j.jamcollsurg.2018.01.049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Inaba CS, Koh CY, Sujatha-Bhaskar S, Pejcinovska M, Nguyen NT. How safe is same-day discharge after laparoscopic sleeve gastrectomy? Surg Obes Relat Dis. 2018. Oct;14(10):1448–1453. doi: 10.1016/j.soard.2018.07.016 [DOI] [PubMed] [Google Scholar]
  • 9.Poelemeijer YQM, Liem RSL, Våge V et al. Perioperative Outcomes of Primary Bariatric Surgery in North-Western Europe: a Pooled Multinational Registry Analysis. Obes Surg. 2018. Dec;28(12):3916–3922. doi: 10.1007/s11695-018-3408-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and Risks of Bariatric Surgery in Adults: A Review. JAMA. 2020. Sep 1;324(9):879–887. doi: 10.1001/jama.2020.12567 [DOI] [PubMed] [Google Scholar]
  • 11.Bellorin O, Abdemur A, Sucandy I, Szomstein S, Rosenthal RJ. Understanding the significance, reasons and patterns of abnormal vital signs after gastric bypass for morbid obesity. Obes Surg. 2011. Jun;21(6):707–13. doi: 10.1007/s11695-010-0221-0 [DOI] [PubMed] [Google Scholar]
  • 12.Hamilton EC, Sims TL, Hamilton TT, Mullican MA, Jones DB, Provost DA. Clinical predictors of leak after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Surg Endosc. 2003. May;17(5):679–84. doi: 10.1007/s00464-002-8819-5 [DOI] [PubMed] [Google Scholar]
  • 13.Jacobs F, Scheerhoorn J, Mestrom E, van der Stam J, Bouwman RA, Nienhuijs S. Reliability of heart rate and respiration rate measurements with a wireless accelerometer in postbariatric recovery. PLoS One. 2021. Apr 28;16(4):e0247903. doi: 10.1371/journal.pone.0247903 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Carandina S, Zulian V, Nedelcu A, Sista F, Danan M, Nedelcu M. Laparoscopic sleeve gastrectomy follow-up: use of connected devices in the postoperative period. Surg Obes Relat Dis. 2019. Jul;15(7):1058–1065. doi: 10.1016/j.soard.2019.03.033 [DOI] [PubMed] [Google Scholar]
  • 15.Nijland LMG, de Castro SMM, Vogel M, Coumou JF, van Rutte PWJ, van Veen RN. Feasibility of Same-Day Discharge After Laparoscopic Roux-en-Y Gastric Bypass Using Remote Monitoring. Obes Surg. 2021. Jul;31(7):2851–2858. doi: 10.1007/s11695-021-05384-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Breteler MJM, KleinJan E, Numan L et al. Are current wireless monitoring systems capable of detecting adverse events in high-risk surgical patients? A descriptive study. Injury. 2020. May;51 Suppl 2:S97–S105. [DOI] [PubMed] [Google Scholar]
  • 17.Weenk M, Koeneman M, van de Belt TH, Engelen LJLPG, van Goor H, Bredie SJH. Wireless and continuous monitoring of vital signs in patients at the general ward. Resuscitation. 2019. Mar;136:47–53. doi: 10.1016/j.resuscitation.2019.01.017 [DOI] [PubMed] [Google Scholar]
  • 18.Eddahchouri Y, Peelen RV, Koeneman M, Touw HRW, van Goor H, Bredie SJH. Effect of continuous wireless vital sign monitoring on unplanned ICU admissions and rapid response team calls: a before-and-after study. Br J Anaesth. 2022. May;128(5):857–863. doi: 10.1016/j.bja.2022.01.036 [DOI] [PubMed] [Google Scholar]
  • 19.Scheerhoorn J, van Ede L, Luyer MDP, Buise MP, Bouwman RA, Nienhuijs SW. Postbariatric EArly discharge Controlled by Healthdot (PEACH) trial: study protocol for a preference-based randomized trial. Trials. 2022. Jan 21;23(1):67. doi: 10.1186/s13063-022-06001-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.van Ede ES, Scheerhoorn J, Bonomi AG, Buise MP, Bouwman RA, Nienhuijs SW. Continuous remote monitoring in post-bariatric surgery patients: development of an early warning protocol. Surg Obes Relat Dis. 2022. Nov;18(11):1298–1303. doi: 10.1016/j.soard.2022.06.018 [DOI] [PubMed] [Google Scholar]
  • 21.Stenberg E, Dos Reis Falcão LF, O’Kane M et al. Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update. World J Surg. 2022. Apr;46(4):729–751. doi: 10.1007/s00268-021-06394-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Poelemeijer YQM, Liem RSL, Nienhuijs SW. A Dutch Nationwide Bariatric Quality Registry: DATO. Obes Surg. 2018. Jun;28(6):1602–1610. doi: 10.1007/s11695-017-3062-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Poelemeijer YQM, Marang-van de Mheen PJ, Wouters MWJM, Nienhuijs SW, Liem RSL. Textbook Outcome: an Ordered Composite Measure for Quality of Bariatric Surgery. Obes Surg. 2019. Apr;29(4):1287–1294. doi: 10.1007/s11695-018-03642-1 [DOI] [PubMed] [Google Scholar]
  • 24.Macaya F, Ryan N, Salinas P, Pocock SJ. Challenges in the Design and Interpretation of Noninferiority Trials: Insights From Recent Stent Trials. J Am Coll Cardiol. 2017. Aug 15;70(7):894–903. [DOI] [PubMed] [Google Scholar]
  • 25.Bai AD, Komorowski AS, Lo CKL et al. McMaster Infectious Diseases Fellow Research Group. Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review. BMC Med Res Methodol. 2021. Apr 19;21(1):75. doi: 10.1186/s12874-021-01260-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wellek S. Statistical methods for the analysis of two-arm non-inferiority trials with binary outcomes. Biom J. 2005. Feb;47(1):48–61; discussion 99–107. doi: 10.1002/bimj.200410090 [DOI] [PubMed] [Google Scholar]
  • 27.Cuzick J, Sasieni P. Interpreting the results of noninferiority trials-a review. Br J Cancer. 2022. Nov;127(10):1755–1759. doi: 10.1038/s41416-022-01937-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Alqahtani AR, Elahmedi M, Amro N et al. Laparoscopic Sleeve Gastrectomy as Day Case Surgery vs Conventional Hospitalization: Results of the DAYSLEEVE Randomized Clinical Trial, Surgery for Obesity and Related Diseases (2022). [DOI] [PubMed] [Google Scholar]
  • 29.Surve A, Cottam D, Zaveri H, et al. Does the future of laparoscopic sleeve gastrectomy lie in the outpatient surgery center? A retrospective study of the safety of 3162 outpatient sleeve gastrectomies. Surg Obes Relat Dis. 2018. Oct;14(10):1442–1447. [DOI] [PubMed] [Google Scholar]
  • 30.Barbat S, Thompson KJ, Mckillop IH, Kuwada TS, Gersin K, Nimeri A. Ambulatory bariatric surgery: does it really lead to higher rates of adverse events? Surg Obes Relat Dis. 2020. Nov;16(11):1713–1720. doi: 10.1016/j.soard.2020.06.051 [DOI] [PubMed] [Google Scholar]
  • 31.Rebibo L, Maurice KK, Nimier M, Ben Rehouma M, Montravers P, Msika S. Laparoscopic sleeve gastrectomy as day-case surgery: a review of the literature. Surg Obes Relat Dis. 2019. Jul;15(7):1211–1217. doi: 10.1016/j.soard.2019.03.020 [DOI] [PubMed] [Google Scholar]
  • 32.Aryaie AH, Reddy V, Dattilo Z, Janik MR. Safety of same-day discharge after laparoscopic sleeve gastrectomy: propensity score-matched analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program Registry. Surg Obes Relat Dis. 2021. Jan;17(1):46–53. doi: 10.1016/j.soard.2020.08.039 [DOI] [PubMed] [Google Scholar]
  • 33.Wasmann KA, Wijsman P, van Dieren S, Bemelman W, Buskens C. Partially randomised patient preference trials as an alternative design to randomised controlled trials: systematic review and meta-analyses. BMJ Open. 2019. Oct 16;9(10):e031151. doi: 10.1136/bmjopen-2019-031151 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Khanna AK, Ahuja S, Weller RS, Harwood TN. Postoperative ward monitoring—Why and what now? Best Pract Res Clin Anaesthesiol. 2019. Jun;33(2):229–245. doi: 10.1016/j.bpa.2019.06.005 [DOI] [PubMed] [Google Scholar]
  • 35.Downey CL, Chapman S, Randell R, Brown JM, Jayne DG. The impact of continuous versus intermittent vital signs monitoring in hospitals: A systematic review and narrative synthesis. Int J Nurs Stud. 2018. Aug;84:19–27. doi: 10.1016/j.ijnurstu.2018.04.013 [DOI] [PubMed] [Google Scholar]
  • 36.Leenen JPL, Leerentveld C, van Dijk JD, van Westreenen HL, Schoonhoven L, Patijn GA, Current Evidence for Continuous Vital Signs Monitoring by Wearable Wireless Devices in Hospitalized Adults: Systematic Review, J Med Internet Res 2020. Jun 17;22(6):e18636. doi: 10.2196/18636 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wells CI, Xu W, Penfold JA, Keane C et al. Wearable devices to monitor recovery after abdominal surgery: scoping review. BJS Open. 2022. Mar 8;6(2):zrac031. doi: 10.1093/bjsopen/zrac031 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Steven E Wolf

17 Nov 2022

PONE-D-22-26848Telemonitoring for perioperative care of outpatient bariatric surgery: preference-based Randomized Clinical TrialPLOS ONE

Dear Dr. van Ede,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 01 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Steven Eric Wolf, MD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

3. We note that the original protocol that you have uploaded as a Supporting Information file contains an institutional logo. As this logo is likely copyrighted, we ask that you please remove it from this file and upload an updated version upon resubmission.

Additional Editor Comments:

Editor - Thank you for submitting your paper to us for review. I sent it to seven distinguished referees for comment and decision of whom two agreed to review; you will see these below. They thought that the paper has merit, but each have raised some substantial issues to be addressed in a revision. Please carefully consider the comments below and reply directly to each in a cover letter with appropriate marked and linked changes to the manuscript. I look forward to seeing the revision, which I will send back to the same referees for further comment and decision. Please understand that this is not a guarantee of future publication, as the revised manuscript itself must stand on its own merit.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I want to commend the authors on a well written manuscript. This article excels both from a topic addressed and content standpoint. We are in an era of increasing demand on the healthcare system. It is more important to than ever before to manage our resources while keeping excellent quality outcomes.

Please edit the first line of the introduction paragraph for it to make better grammatical sense. Other than that no issues or concerns identified.

Reviewer #2: Line 130-133 The description is not clear here. Those events mean “a perfect convalescent”?

Line 144 what test was used for the sample size calculation?

Line 153: Which non-parametric test was used? Need to clarify which outcome was compared using t-test and which was compared using the non-parametric test.

Line 155: It is not appropriate to use two -sided p value for the non-inferiority trial.

Line 152 & 156 what group means were mentioned here?

Line 178 the result of primary outcome comparison is not clearly written for a non-inferiority test. Line 181. What are the 95% confidence intervals for event rates? One sided or two-sided. The confidence interval of event rate should be reported in the text and in table 2.

Line 179 and table 2: What is the purpose to use risk ratio? The estimated risk ratio does not seem correct. Did you use odds ratio?

Line 180 & Table 2: what are the sample sizes for ITT and per-protocol? Is there any imputation used? If no data is missing (as specified in the title), what is the difference between the two?

Table 2. Add total N of each group. Omit risk ratio and add 95% CI for event rate. For mortality and etc., report N (%).

Line 224 all patients were prescribed. Why n=10 and 9 in RM and SC respectively?

Table 3 is confusing.

Table 4 add (%)

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Feb 22;18(2):e0281992. doi: 10.1371/journal.pone.0281992.r002

Author response to Decision Letter 0


12 Dec 2022

Dear Editors

Thank you for the opportunity to resubmit our manuscript. The comments of the reviewers were useful and have been addressed to accordingly, see below. Looking forward to hear from you.

Sincerely yours,

Lisa van Ede

On behalf of my co-authors.

Responses to the reviewers;

Reviewer #1

Please edit the first line of the introduction paragraph for it to make better grammatical sense. Other than that no issues or concerns identified. Thank you for this comment, we have altered this sentence.

Reviewer #2:

Line 130-133 The description is not clear here. Those events mean “a perfect convalescent”? Indeed, a perfect convalescent, outcome as hoped and described in a textbook, we clarified this as a composite measure of clinical process indicators. Textbook Outcome is realized for those who reached all desired short-term health indicators.

Line 144 what test was used for the sample size calculation? Sample size was calculated using an uncorrected chi-square statistic. This is added in the manuscript.

Line 153: Which non-parametric test was used? Need to clarify which outcome was compared using t-test and which was compared using the non-parametric test. The non-parametric test that was used was a Mann-Whitey U test. This is added to the manuscript. Also, we clarified which test was used for what outcome.

Line 155: It is not appropriate to use two -sided p value for the non-inferiority trial. Thank you for this comment, it is correct indeed that the results should be presented as one-sided p-values. The p-values in the first manuscript were results of chi-square tests. Now, these p-values were changed for p-value for non-inferiority testing using the Wald Method which is more correct. The numbers are altered in the abstract, main text and table 2.

Wellek S. Statistical methods for the analysis of two-arm non-inferiority trials with binary outcomes. Biom J. 2005 Feb;47(1):48-61; discussion 99-107.

Line 152 & 156 what group means were mentioned here? Specifications of group means of patients characteristics have been clarified.

Line 178 the result of primary outcome comparison is not clearly written for a non-inferiority test. The results in the paragraph for primary outcomes are rewritten using examples of existing literature and source 2

2. Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG; CONSORT Group. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.

JAMA. 2012 Dec 26;308(24):2594-604.

Line 181. What are the 95% confidence intervals for event rates? One sided or two-sided. The confidence interval of event rate should be reported in the text and in table 2. The 95% CI was only calculated on the combined outcome measure because the individual event rates were too low. The result of the individual events would not be reliable as the primary outcome was a combined measure, in accordance with advice of consulted hospital's methodologist. For this reason, also the p-values behind the event rates were removed from table 2. The 95% CI of the combined textbook outcome is presented 2-sided. This information is added to the methodology section.

Line 179 and table 2: What is the purpose to use risk ratio? The risk ratio was assessed and presented conform the consort guidelines for non-inferiority trials with binary outcomes (see link below). According to the guidelines, also the risk difference is added to the method and result section.

http://www.consort-statement.org/checklists/view/650-non-inferiority-and-equivalence-trials/827-binary-outcomes

The estimated risk ratio does not seem correct. Did you use odds ratio? Correct, presented RR had to be adjusted. As a result also the Confidence Interval enlarged for which discussion and conclusion had to be adjusted.

Line 180 & Table 2: what are the sample sizes for ITT and per-protocol? Is there any imputation used? If no data is missing (as specified in the title), what is the difference between the two? It is correct that no data was missing, this was not a distinctive in analysis. Per-protocol analysis focused on those who were actually discharged the same day. In the ITT approach also those who did not succeed to leave the same day were included. Additional info has been added to the method section.

Table 2. Add total N of each group. Omit risk ratio and add 95% CI for event rate. For mortality and etc., report N (%). The table is adjusted except for 95% CI for event rates. The 95% CI was only calculated on the combined outcome measure because the individual event rates were too low. The result of the individual events would not be reliable as the primary outcome was a combined measure, in accordance with advice of consulted hospital's methodologist. Also for this reason the p-values behind event rates are removed.

Line 224 all patients were prescribed. Why n=10 and 9 in RM and SC respectively? Correct, it was a typo error, altered into ‘In addition, patients from both groups were prescribed the same amount of opioids after being discharged (10/102 (11%) versus 9/100 (9%) in SC group p=0.82).’

Table 3 is confusing. The layout is upgraded for more clarification.

Table 4 add (%) Adjusted

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Steven E Wolf

7 Feb 2023

Telemonitoring for perioperative care of outpatient bariatric surgery: preference-based Randomized Clinical Trial

PONE-D-22-26848R1

Dear Dr. van Ede,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Steven E. Wolf, MD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Acceptance letter

Steven E Wolf

10 Feb 2023

PONE-D-22-26848R1

Telemonitoring for perioperative care of outpatient bariatric surgery: preference-based Randomized Clinical Trial

Dear Dr. van Ede:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Steven E. Wolf

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist

    (PDF)

    S1 File. Study protocol.

    (PDF)

    S2 File

    (PDF)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    The file ia available from the Open Science Framework database Accession number: DOI 10.17605/OSF.IO/256MN).


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES